The single most useful thing to understand about the European Specialty Examination in Gastroenterology and Hepatology is that it is really two examinations wearing one name. Luminal gastroenterology and hepatology are different diseases, different reasoning, different investigations and different therapeutics, and almost every candidate has spent more time in one than the other. The exam does not care which. It samples both, and the marks lost are almost always in the half you have not been living in. Confirm the current format and curriculum with the examining body, since European examinations are revised periodically.
Key takeaways
- Treat this as two exams: luminal gastroenterology and hepatology, tracked separately in your data.
- Add pancreatobiliary disease and nutrition, which are the two domains candidates most reliably neglect.
- Sort your errors by decision stage, because diagnosis, intervention and surveillance fail differently.
- Surveillance intervals are pure recall, entirely finite, and among the cheapest marks in the paper.
- Endoscopic and radiological interpretation is examined inside management, not as a separate subject.
Two specialties, one paper
Look honestly at where your clinical time has gone. Most candidates arrive at this exam having spent the bulk of their training in one half: heavy endoscopy and inflammatory bowel disease, or a liver unit with transplant work and decompensated cirrhosis.
Your question bank percentage will look reasonable, because your strong half is carrying it. Split it, and the picture usually changes sharply. Track luminal and hepatology as separate domains from the start, and set separate accuracy targets for each. If you are at seventy per cent overall, and that is eighty in your specialty and fifty-five in the other, you do not have a seventy per cent problem, you have a specific and fixable one.
The four domains, including the two you will neglect
Divide the curriculum deliberately, because the division tells you where your blind spots are.
Luminal gastroenterology. Inflammatory bowel disease, coeliac disease, functional disorders, oesophageal disease including Barrett's, gastrointestinal bleeding, motility, and colorectal neoplasia.
Hepatology. Viral hepatitis, autoimmune liver disease, metabolic and alcohol-related liver disease, cirrhosis and its complications, portal hypertension, liver transplantation, and acute liver failure.
Pancreatobiliary. Acute and chronic pancreatitis, pancreatic and biliary neoplasia, gallstone disease and its complications, and cholangitis. This domain sits between the two big ones and belongs comfortably to neither, which is precisely why it goes unrevised.
Nutrition. Malnutrition, refeeding, parenteral and enteral feeding, intestinal failure, and short bowel. It is the least glamorous domain in the curriculum, it appears in the exam, and almost nobody revises it. That combination makes it unusually good value.
Sort your errors by decision stage
Gastroenterology questions cluster around a small number of decision stages, and your errors will usually cluster in one of them rather than in a disease.
Diagnosis. Which condition is this, from the history, the bloods, the serology, the imaging or the biopsy.
Investigation choice. Which test next, and specifically which endoscopic or radiological modality, and when.
Medical management. Which therapy, at what point in the sequence, with what monitoring.
Intervention. When endoscopic or radiological intervention is indicated, which one, and when to escalate to surgery.
Surveillance. Who is followed up, how, and at what interval.
If your mistakes gather in one stage across several diseases, you have found a cross-cutting weakness that is fixable once, rather than five disease weaknesses fixable five times.
Surveillance intervals are the cheapest marks in the exam
This deserves a section because candidates consistently under-invest in it.
Surveillance in gastroenterology is heavily protocolised: Barrett's oesophagus by dysplasia grade and segment length, colonic polyps by number, size and histology, varices after a bleed and in compensated cirrhosis, hepatocellular carcinoma screening in whom and how often, colonoscopic surveillance in inflammatory bowel disease by risk stratum, and follow-up after resection.
This content has two properties that make it exceptional value. It is finite, so it can be learned to completion in a way that clinical reasoning cannot. And it is pure recall, so it decays, which means most of your competitors will half-know it.
Do not read it. Space it. These are exactly the numbers that feel secure the day you meet them and are gone by the exam, and spaced retrieval is the only thing that holds them.
Endoscopy and imaging live inside the management question
A structural warning that applies to this exam more than most.
Candidates revise the diseases and then treat endoscopic images, cross-sectional imaging, histology and manometry as a separate topic to be attacked later. The exam does not present them separately. It shows you a finding and asks what you do with it, which means interpretation and management arrive in the same question.
So learn the images inside the disease. When you revise variceal bleeding, learn what the varices and the stigmata of recent haemorrhage look like and what each mandates. When you revise inflammatory bowel disease, learn the endoscopic appearances that distinguish the conditions and the ones that change management. When you revise pancreatitis, learn the imaging that establishes severity and complications, because that is what determines the answer.
The hepatology traps
Two specific patterns recur, and both are worth naming.
The first is decompensation. A great many hepatology questions are not really about the liver disease at all, but about the recognition and management of its complications: the encephalopathy, the ascites and its infection, the bleeding, the renal dysfunction. The underlying aetiology is often incidental, and candidates who focus on identifying the cause miss that the question is about the complication in front of them.
The second is the transplant decision, where the question is frequently one of timing, eligibility and contraindication rather than of medicine, and where the answer turns on scores and criteria that are pure recall and therefore, again, cheap marks that decay.
Where iatroX fits
iatroX's ESEGH bank covers both halves of this exam and tracks them separately, so you can see immediately whether your marks are being lost in luminal disease or in hepatology rather than blending them into one flattering figure, and the adaptive engine can rebalance your exposure towards the half you have been neglecting rather than the half you enjoy. Spaced repetition returns the surveillance intervals, scores and thresholds that decay fastest, and missed questions can be opened in the Socratic Tutor, which asks you to reason before it explains. Try it with free sample questions at iatroX. For separating a topic weakness from a decision-stage weakness, see finding hidden weaknesses in your question bank data.
Frequently asked questions
How should I split my revision between gastroenterology and hepatology? According to your data, not your instincts. Track the two as separate domains, because almost every candidate is stronger in one and a blended percentage conceals it. The marks are lost in the half you have not been working in.
Which domains do ESEGH candidates most often neglect? Pancreatobiliary disease and nutrition. Both sit between the two main specialties and belong comfortably to neither, which is exactly why they go unrevised, and nutrition in particular is unusually good value.
Are surveillance intervals worth memorising? Yes, and they are among the cheapest marks available. The content is finite and purely recall-based, which means it decays and most candidates only half-know it. Space it rather than reading it.
Should I revise endoscopic images separately? No. The exam presents a finding and asks what you do with it, so interpretation and management arrive in the same question. Learn the appearances inside each disease, alongside the decisions they trigger.